Raymond James & Associates United Therapeutics Corp Transaction History
Raymond James & Associates
- $161 Billion
- Q3 2024
A detailed history of Raymond James & Associates transactions in United Therapeutics Corp stock. As of the latest transaction made, Raymond James & Associates holds 35,751 shares of UTHR stock, worth $12.9 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
35,751
Previous 35,142
1.73%
Holding current value
$12.9 Million
Previous $11.2 Million
14.45%
% of portfolio
0.01%
Previous 0.01%
Shares
27 transactions
Others Institutions Holding UTHR
# of Institutions
671Shares Held
42.3MCall Options Held
194KPut Options Held
295K-
Black Rock Inc. New York, NY5.47MShares$1.97 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.41MShares$1.59 Billion0.03% of portfolio
-
Wellington Management Group LLP Boston, MA3.17MShares$1.14 Billion0.2% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.86MShares$1.03 Billion15.42% of portfolio
-
State Street Corp Boston, MA2.24MShares$808 Million0.03% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $16.4B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...